Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04614324 · ClinicalTrials.gov registry record · NA
A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)
A NA study of Chronic Rhinitis, sponsored by Aerin Medical.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 15
- Study locations
NCT04614324: Completed NA study of Chronic Rhinitis, sponsored by Aerin Medical.
NCT04614324 is a NA study of Chronic Rhinitis that has completed, run by Aerin Medical. The registered enrollment target is 129 participants, above the 76-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (70% higher). The trial reports 15 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04614324, a NA study of Chronic Rhinitis, has completed, sponsored by Aerin Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 15
- Study locations
Study Summary
Post-market study to continue to evaluate the effectiveness of the RhinAer ARC Stylus for chronic rhinitis.
Primary Outcome
The rTNSS (Total Nasal Symptom Score) is a brief questionnaire developed to assess the severity of symptoms in individuals with rhinitis, particularly allergic rhinitis The questionnaire consists of questions that evaluate the following 4 symptoms of Nasal Congestion, Runny Nose, Nasal Itching and Sneezing. Each symptom is rated on a 4-point scale from "0" (no symptoms), "1" (mild symptoms), "2" (moderate symptoms" and "3" (severe symptoms). The total score is calculated by summing up the indi
Conditions Studied
Interventions
- DEVICE RhinAer ARC Stylus
Study Locations (15)
Florida
- ENT Associates of South Florida - Boca Raton
- ENT and Allergy Associates of Florida - Port Saint Lucie
- Florida ENT and Allergy - Tampa
Other
- HNO-ZENTRUM am Kudamm - Berlin
- Universitatsklinikum Carl Gustav Carus Dresden - Dresden
- Facharzt für Hals- Nasen- und Ohrenkrankheiten Allergologie Plastische Operationen - Göttingen
California
- Sacramento ENT - Roseville
- University of California, San Francisco - San Francisco
Texas
- Fort Worth ENT - Fort Worth
- ENT and Allergy Associates of Texas - McKinney
Arizona
- Arizona Desert ENT Specialists - Goodyear
Illinois
- Chicago Nasal and Sinus Center - Chicago
Kentucky
- Advanced ENT and Allergy - Louisville
Louisiana
- Baton Rouge General / Sinus and Nasal Specialists of Louisiana - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
What the finished NCT04614324 record still lists
NCT04614324 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (70% higher).
The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which RhinAer ARC Stylus is the first listed.
NCT04614324 lists 15 locations in 9 states (Florida, Other, California).
Frequently Asked Questions
What is clinical trial NCT04614324 about?
NCT04614324 is a clinical study titled "A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)". Post-market study to continue to evaluate the effectiveness of the RhinAer ARC Stylus for chronic rhinitis.
What is the current status of trial NCT04614324?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2020-10-05. Estimated completion is 2024-12-20.
What conditions does trial NCT04614324 study?
This clinical trial studies the following conditions: Chronic Rhinitis.
What interventions are being tested in trial NCT04614324?
The interventions under investigation include: RhinAer ARC Stylus (DEVICE).
Who is sponsoring clinical trial NCT04614324?
This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04614324 being conducted?
This trial has 15 study locations across Arizona, California, Florida, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of RhinAer Stylus for Treating Chronic Rhinitis
ACTIVE NOT RECRUITING · NA
-
NEUROMARK Registry Study
ACTIVE NOT RECRUITING · NA
-
Multi-Treatment PNN Modulation for Chronic Rhinitis
COMPLETED · NA
-
ClariFix Rhinitis RCT
COMPLETED · NA
-
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)
COMPLETED · NA
-
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI